ArticlePatient preference and adherence2016

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?

Hsin-Hua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.